However, it is worth briefly mentioning some important driver mutations, including mutations of the BRAF oncogene, that are present in 60% of all cutaneous melanomas, mutation in the oncogene NRAS and the tumour suppressor gene neurofibromatosis 1 (NF1). The gene discussed is NF1; the disease is cutaneous melanoma.